From: Steven Nissen, MD	Category: JAMA REPORT
City: Cleveland	Language: English

JAMA Report: Dr Steven Nissen, a cardiologist at the Cleveland Clinic, presents a study reported in JAMA that a new wieght loss drug may help patients with coronary artery disease. The drug, Rimonabant, is used in Europe, but not yet approved in the United States for weight loss. Although further studies are necessary, this study did show some benefit in patients with heart disease.

From: Paul Aisen, MD	Category: JAMA REPORT
City: San Diego	Language: English

JAMA Report: A new study looked at high dose vitamins and Alzheimer's disease. The study did show that the high dose vitamins did lower homocysteine levels, which is associated with Alzheimer's disease. However, having the lower levels of homocysteine did not tranlate into slowing of the disease progression in Alzheimers.

From: Steven Dekosky, MD	Category: JAMA REPORT
City: Charlottesville	Language: English

In a new study in JAMA it was found that ginko biloba, a commonly used supplement, did not prevent onset of dementia. Dr. Steven Dekosky, the Dean of Medicine at the Univ. of Virginia, presents the study.

From: Robert Wallace, MD	Category: JAMA REPORT
City: Iowa City	Language: English

JAMA Report: THe womens health initiative was a major study which was halted after researchers found increased health risks in patients taking hormone replacement therapy. Now a new study in JAMA shows that the risk on breast cancer continues 3 years after stopping the medications.